Activity of the integrase inhibitor S/GSK1349572 in subjects with HIV exhibiting raltegravir resistance: week 24 results of the VIKING study (ING112961)

by Eron, J, Livrozet, JM, Morlat, P, Lazzarin, A, Katlama, C, Hawkins, T, Fujiwara, T, Cuffe, R, Vavro, C, Santiago, J, Ait-Khaled, M, Min, S, Yeo, JM
Published 2010

Antiviral activity of dolutegravir in subjects with failure on an integrase inhibitor-based regimen: week 24 phase 3 results from VIKING-3

by Nichols, G, Mills, A, Grossberg, R, Lazzarin, A, Maggiolo, F, Molina, J, Pialoux, G, Wright, D, Ait-Khaled, M, Huang, J, Vavro, C, Wynne, B, Yeo, J
Published 2012